ACS to Award Clinical Research Professorship

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 9
Volume 6
Issue 9

ATLANTA, Ga-The American Cancer Society is inviting proposals from candidates for the newly established Harry and Elsa Jiler American Cancer Society Clinical Research Professorship.

ATLANTA, Ga—The American Cancer Society is inviting proposals from candidates for the newly established Harry and Elsa Jiler American Cancer Society Clinical Research Professorship.

The grant is intended for an outstanding clinician-scientist in mid-career who has made significant contributions in cancer research and is considered an exceptional leader in his or her field. Applicants may be active in any area of clinical or epidemiological cancer research.

The grant provides up to $60,000 annually that can be apportioned to salary and/or research project support at the discretion of the awardee. It is awarded for a period of five years and may be renewed once.

Applications are furnished by the American Cancer Society after discussion with the Scientific Program Director (Ralph Vogler, MD, telephone: 404-329-7542 or e-mail: rvogler@cancer.org) or the Vice President for Extramural Grants (John Stevens, MD, telephone: 404-329-7550 or e-mail: jstevens@cancer.org). The deadline for receipt of applications is October 1, 1997.

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content